Compared with healthy controls, after 2 and 3 vaccine doses, patients with IBD treated with anti-TNF had a significantly higher percentage of medium avidity S-specific IgG and a correspondingly lower percentage of high avidity IgG (Figure 7, D and E). Here, TNF is linked to inflammatory bowel disease.